Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 283

    1.

    Report from the Radiation Therapy Committee of the Southwest Oncology Group (SWOG): research objectives Workshop 2008.

    Okunieff P, Kachnic LA, Constine LS, Fuller CD, Gaspar LE, Hayes DF, Hooks J, Ling C, Meyskens FL Jr, Philip PA, Raben D, Smalley SR, Swanson GP, Teicher BA, Thomas CR Jr, Vikram B, Zelefsky MJ, Baker LH.

    Clin Cancer Res. 2009 Sep 15;15(18):5663-70. Epub 2009 Sep 1.PMID: 19723641 [PubMed - in process]Related articles

    2.

    Food extracts for chemoprevention: quo vadis?

    Meyskens FL Jr.

    Cancer Prev Res (Phila Pa). 2009 Jul;2(7):608-10. No abstract available. PMID: 19584073 [PubMed - indexed for MEDLINE]Related articles

    3.

    Risk of cardiovascular events in a randomized placebo-controlled, double-blind trial of difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas.

    Zell JA, Pelot D, Chen WP, McLaren CE, Gerner EW, Meyskens FL.

    Cancer Prev Res (Phila Pa). 2009 Mar;2(3):209-12. Epub 2009 Mar 3.PMID: 19258540 [PubMed - indexed for MEDLINE]Related articles

    4.

    Combination chemoprevention for colon cancer targeting polyamine synthesis and inflammation.

    Gerner EW, Meyskens FL Jr.

    Clin Cancer Res. 2009 Feb 1;15(3):758-61. Review.PMID: 19188144 [PubMed - indexed for MEDLINE]Related articles

    5.

    Longitudinal assessment of air conduction audiograms in a phase III clinical trial of difluoromethylornithine and sulindac for prevention of sporadic colorectal adenomas.

    McLaren CE, Fujikawa-Brooks S, Chen WP, Gillen DL, Pelot D, Gerner EW, Meyskens FL Jr.

    Cancer Prev Res (Phila Pa). 2008 Dec;1(7):514-21.PMID: 19139001 [PubMed - indexed for MEDLINE]Related articles

    6.

    Nitric oxide initiates progression of human melanoma via a feedback loop mediated by apurinic/apyrimidinic endonuclease-1/redox factor-1, which is inhibited by resveratrol.

    Yang Z, Yang S, Misner BJ, Chiu R, Liu F, Meyskens FL Jr.

    Mol Cancer Ther. 2008 Dec;7(12):3751-60.PMID: 19074850 [PubMed - indexed for MEDLINE]Related articles

    7.

    Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

    Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, Ford LG, Parnes HL, Minasian LM, Gaziano JM, Hartline JA, Parsons JK, Bearden JD 3rd, Crawford ED, Goodman GE, Claudio J, Winquist E, Cook ED, Karp DD, Walther P, Lieber MM, Kristal AR, Darke AK, Arnold KB, Ganz PA, Santella RM, Albanes D, Taylor PR, Probstfield JL, Jagpal TJ, Crowley JJ, Meyskens FL Jr, Baker LH, Coltman CA Jr.

    JAMA. 2009 Jan 7;301(1):39-51. Epub 2008 Dec 9.PMID: 19066370 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Retinol, vitamins, and cancer prevention: 25 years of learning and relearning.

    Goodman GE, Alberts DS, Meyskens FL.

    J Clin Oncol. 2008 Dec 1;26(34):5495-6. Epub 2008 Nov 3. No abstract available. PMID: 18981460 [PubMed - indexed for MEDLINE]Related articles

    9.

    MiTF regulates cellular response to reactive oxygen species through transcriptional regulation of APE-1/Ref-1.

    Liu F, Fu Y, Meyskens FL Jr.

    J Invest Dermatol. 2009 Feb;129(2):422-31. Epub 2008 Oct 30.PMID: 18971960 [PubMed - indexed for MEDLINE]Related articles

    10.

    Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: a randomized placebo-controlled, double-blind trial.

    Meyskens FL Jr, McLaren CE, Pelot D, Fujikawa-Brooks S, Carpenter PM, Hawk E, Kelloff G, Lawson MJ, Kidao J, McCracken J, Albers CG, Ahnen DJ, Turgeon DK, Goldschmid S, Lance P, Hagedorn CH, Gillen DL, Gerner EW.

    Cancer Prev Res (Phila Pa). 2008 Jun;1(1):32-8.PMID: 18841250 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Apurinic/apyrimidinic endonuclease /redox effector factor-1(APE/Ref-1) a unique target for the prevention and treatment of human melanoma.

    Yang S, Meyskens FL.

    Antioxid Redox Signal. 2008 Aug 20. [Epub ahead of print]PMID: 18715151 [PubMed - as supplied by publisher]Related articles

    12.

    Melanosomal damage in normal human melanocytes induced by UVB and metal uptake--a basis for the pro-oxidant state of melanoma.

    Gidanian S, Mentelle M, Meyskens FL Jr, Farmer PJ.

    Photochem Photobiol. 2008 May-Jun;84(3):556-64. Epub 2008 Mar 7.PMID: 18331399 [PubMed - indexed for MEDLINE]Related articles

    13.

    The effect of difluoromethylornithine on decreasing prostate size and polyamines in men: results of a year-long phase IIb randomized placebo-controlled chemoprevention trial.

    Simoneau AR, Gerner EW, Nagle R, Ziogas A, Fujikawa-Brooks S, Yerushalmi H, Ahlering TE, Lieberman R, McLaren CE, Anton-Culver H, Meyskens FL Jr.

    Cancer Epidemiol Biomarkers Prev. 2008 Feb;17(2):292-9.PMID: 18268112 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    UV or not UV: metals are the answer.

    Meyskens FL Jr, Berwick M.

    Cancer Epidemiol Biomarkers Prev. 2008 Feb;17(2):268-70. No abstract available. PMID: 18268109 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    End-of-Life care: guidelines for patient-centered communication.

    Ngo-Metzger Q, August KJ, Srinivasan M, Liao S, Meyskens FL Jr.

    Am Fam Physician. 2008 Jan 15;77(2):167-74.PMID: 18246886 [PubMed - indexed for MEDLINE]Related articles

    16.

    Another negative chemoprevention trial: what can we learn?

    Meyskens FL Jr.

    Clin Cancer Res. 2008 Jan 1;14(1):2-3. No abstract available. PMID: 18172244 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Survival for patients with invasive cutaneous melanoma among ethnic groups: the effects of socioeconomic status and treatment.

    Zell JA, Cinar P, Mobasher M, Ziogas A, Meyskens FL Jr, Anton-Culver H.

    J Clin Oncol. 2008 Jan 1;26(1):66-75.PMID: 18165642 [PubMed - indexed for MEDLINE]Related articles

    18.

    Common and distinct mechanisms of different redox-active carcinogens involved in the transformation of mouse JB6P+ cells.

    Yang S, Misner B, Chiu R, Meyskens FL Jr.

    Mol Carcinog. 2008 Jul;47(7):485-91.PMID: 18092320 [PubMed - indexed for MEDLINE]Related articles

    19.

    Redox effector factor-1, combined with reactive oxygen species, plays an important role in the transformation of JB6 cells.

    Yang S, Misner BJ, Chiu RJ, Meyskens FL Jr.

    Carcinogenesis. 2007 Nov;28(11):2382-90. Epub 2007 Jun 12.PMID: 17566060 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Development of a polyamine database for assessing dietary intake.

    Zoumas-Morse C, Rock CL, Quintana EL, Neuhouser ML, Gerner EW, Meyskens FL Jr.

    J Am Diet Assoc. 2007 Jun;107(6):1024-7.PMID: 17524725 [PubMed - indexed for MEDLINE]Related articles

    21.

    Antagonism of p66shc by melanoma inhibitory activity.

    Kasuno K, Naqvi A, Dericco J, Yamamori T, Santhanam L, Mattagajasingh I, Yang S, Meyskens FL, Bosserhoff AK, Irani K.

    Cell Death Differ. 2007 Aug;14(8):1414-21. Epub 2007 Apr 13.PMID: 17431427 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Rationale for, and design of, a clinical trial targeting polyamine metabolism for colon cancer chemoprevention.

    Gerner EW, Meyskens FL Jr, Goldschmid S, Lance P, Pelot D.

    Amino Acids. 2007 Aug;33(2):189-95. Epub 2007 Mar 30. Review.PMID: 17396214 [PubMed - indexed for MEDLINE]Related articles

    23.

    New perspectives on melanoma pathogenesis and chemoprevention.

    Meyskens FL Jr, Farmer PJ, Yang S, Anton-Culver H.

    Recent Results Cancer Res. 2007;174:191-5. Review.PMID: 17302196 [PubMed - indexed for MEDLINE]Related articles

    24.

    Reactive oxygen species: a breath of life or death?

    Fruehauf JP, Meyskens FL Jr.

    Clin Cancer Res. 2007 Feb 1;13(3):789-94. Review.PMID: 17289868 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    A novel three-dimensional model to quantify metastatic melanoma invasion.

    Ghajar CM, Suresh V, Peyton SR, Raub CB, Meyskens FL Jr, George SC, Putnam AJ.

    Mol Cancer Ther. 2007 Feb;6(2):552-61. Epub 2007 Jan 31.PMID: 17267658 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    Development and characteristics of a human cell assay for screening agents for melanoma prevention.

    Elmore E, Jain A, Siddiqui S, Tohidian N, Meyskens FL, Steele VE, Redpath JL.

    Melanoma Res. 2007 Feb;17(1):42-50.PMID: 17235241 [PubMed - indexed for MEDLINE]Related articles

    27.

    American Society of Preventive Oncology Distinguished Career Achievement Lecture 2006--Enjoy the journey: the long and winding road of chemoprevention agent development.

    Meyskens FL Jr.

    Cancer Epidemiol Biomarkers Prev. 2006 Nov;15(11):2038-41. No abstract available. PMID: 17119025 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer--a plan to move forward.

    Kelloff GJ, Lippman SM, Dannenberg AJ, Sigman CC, Pearce HL, Reid BJ, Szabo E, Jordan VC, Spitz MR, Mills GB, Papadimitrakopoulou VA, Lotan R, Aggarwal BB, Bresalier RS, Kim J, Arun B, Lu KH, Thomas ME, Rhodes HE, Brewer MA, Follen M, Shin DM, Parnes HL, Siegfried JM, Evans AA, Blot WJ, Chow WH, Blount PL, Maley CC, Wang KK, Lam S, Lee JJ, Dubinett SM, Engstrom PF, Meyskens FL Jr, O'Shaughnessy J, Hawk ET, Levin B, Nelson WG, Hong WK; AACR Task Force on Cancer Prevention.

    Clin Cancer Res. 2006 Jun 15;12(12):3661-97. Review.PMID: 16778094 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    Predicting risk for the appearance of melanoma.

    Meyskens FL Jr, Ransohoff DF.

    J Clin Oncol. 2006 Aug 1;24(22):3522-3. Epub 2006 May 25. No abstract available. PMID: 16728487 [PubMed - indexed for MEDLINE]Related articles

    30.

    Microphthalmic-associated transcription factor integrates melanocyte biology and melanoma progression.

    Goding C, Meyskens FL Jr.

    Clin Cancer Res. 2006 Feb 15;12(4):1069-73. No abstract available. PMID: 16489058 [PubMed - indexed for MEDLINE]Related articlesFree article

    32.

    Principles of cancer prevention.

    Meyskens FL Jr, Tully P.

    Semin Oncol Nurs. 2005 Nov;21(4):229-35. Review.PMID: 16293510 [PubMed - indexed for MEDLINE]Related articles

    33.

    Redox regulation by intrinsic species and extrinsic nutrients in normal and cancer cells.

    McEligot AJ, Yang S, Meyskens FL Jr.

    Annu Rev Nutr. 2005;25:261-95. Review.PMID: 16011468 [PubMed - indexed for MEDLINE]Related articles

    34.

    Talking to a patient.

    Meyskens FL Jr, Hietanen P, Tannock IF.

    J Clin Oncol. 2005 Jul 1;23(19):4463-4. No abstract available. PMID: 15994158 [PubMed - indexed for MEDLINE]Related articles

    35.

    Diet and cancer: the disconnect between epidemiology and randomized clinical trials.

    Meyskens FL Jr, Szabo E.

    Cancer Epidemiol Biomarkers Prev. 2005 Jun;14(6):1366-9.PMID: 15941942 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    An educational program to increase cervical and breast cancer screening in Hispanic women: a Southwest Oncology Group study.

    Hansen LK, Feigl P, Modiano MR, Lopez JA, Escobedo Sluder S, Moinpour CM, Pauler DK, Meyskens FL.

    Cancer Nurs. 2005 Jan-Feb;28(1):47-53.PMID: 15681982 [PubMed - indexed for MEDLINE]Related articles

    37.

    Diet and melanoma in a case-control study.

    Meyskens FL Jr, Farmer PJ, Anton-Culver H.

    Cancer Epidemiol Biomarkers Prev. 2005 Jan;14(1):293. No abstract available. PMID: 15668513 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    How should we move the field of chemopreventive agent development forward in a productive manner?

    Meyskens FL, Szabo E.

    Recent Results Cancer Res. 2005;166:113-24. Review.PMID: 15648187 [PubMed - indexed for MEDLINE]Related articles

    39.

    Can a marker be a surrogate for development of cancer, and would we know it if it exists?

    Armstrong WB, Taylor TH, Meyskens FL.

    Recent Results Cancer Res. 2005;166:99-112. Review.PMID: 15648186 [PubMed - indexed for MEDLINE]Related articles

    40.

    Disulfiram facilitates intracellular Cu uptake and induces apoptosis in human melanoma cells.

    Cen D, Brayton D, Shahandeh B, Meyskens FL Jr, Farmer PJ.

    J Med Chem. 2004 Dec 30;47(27):6914-20.PMID: 15615540 [PubMed - indexed for MEDLINE]Related articles

    41.

    Nuclear morphometry and molecular biomarkers of actinic keratosis, sun-damaged, and nonexposed skin.

    Carpenter PM, Linden KG, McLaren CE, Li KT, Arain S, Barr RJ, Hite P, Sun JD, Meyskens FL Jr.

    Cancer Epidemiol Biomarkers Prev. 2004 Dec;13(12):1996-2002.PMID: 15598753 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    The Beta-Carotene and Retinol Efficacy Trial: incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping beta-carotene and retinol supplements.

    Goodman GE, Thornquist MD, Balmes J, Cullen MR, Meyskens FL Jr, Omenn GS, Valanis B, Williams JH Jr.

    J Natl Cancer Inst. 2004 Dec 1;96(23):1743-50.PMID: 15572756 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    Polyamines and cancer: old molecules, new understanding.

    Gerner EW, Meyskens FL Jr.

    Nat Rev Cancer. 2004 Oct;4(10):781-92. Review.PMID: 15510159 [PubMed - indexed for MEDLINE]Related articles

    44.

    Alterations in activating protein 1 composition correlate with phenotypic differentiation changes induced by resveratrol in human melanoma.

    Yang S, Meyskens FL Jr.

    Mol Pharmacol. 2005 Jan;67(1):298-308. Epub 2004 Oct 18.PMID: 15492115 [PubMed - indexed for MEDLINE]Related articlesFree article

    45.

    Screening for cancer: valuable or not?

    Meyskens FL.

    Curr Oncol Rep. 2004 Nov;6(6):485-90. Review.PMID: 15485619 [PubMed - indexed for MEDLINE]Related articles

    46.

    Pulling the trigger.

    Meyskens FL Jr, Fetting JH.

    J Clin Oncol. 2004 Sep 1;22(17):3644-5. No abstract available. PMID: 15337815 [PubMed - indexed for MEDLINE]Related articles

    47.

    Etiologic pathogenesis of melanoma: a unifying hypothesis for the missing attributable risk.

    Meyskens FL Jr, Farmer PJ, Anton-Culver H.

    Clin Cancer Res. 2004 Apr 15;10(8):2581-3. No abstract available. PMID: 15102657 [PubMed - indexed for MEDLINE]Related articlesFree article

    48.

    Comparative expression of NFkappaB proteins in melanocytes of normal skin vs. benign intradermal naevus and human metastatic melanoma biopsies.

    McNulty SE, del Rosario R, Cen D, Meyskens FL Jr, Yang S.

    Pigment Cell Res. 2004 Apr;17(2):173-80.PMID: 15016307 [PubMed - indexed for MEDLINE]Related articles

    49.

    During human melanoma progression AP-1 binding pairs are altered with loss of c-Jun in vitro.

    Yang S, McNulty S, Meyskens FL Jr.

    Pigment Cell Res. 2004 Feb;17(1):74-83.PMID: 14717848 [PubMed - indexed for MEDLINE]Related articles

    50.

    Cervical cancer chemoprevention, vaccines, and surrogate endpoint biomarkers.

    Follen M, Meyskens FL Jr, Alvarez RD, Walker JL, Bell MC, Storthz KA, Sastry J, Roy K, Richards-Kortum R, Cornelison TL.

    Cancer. 2003 Nov 1;98(9 Suppl):2044-51. Review.PMID: 14603541 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...